Vikas Lifecare Limited has informed regarding Disclosure of material issue i.e. Fund Raising and other matters
VIKASLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vikas Lifecare's Board has approved raising funds up to Rs. 200 crores through issuance of warrants and/or equity shares on a preferential basis under SEBI ICDR Regulations 2018. The issue price will follow SEBI's pricing formula. The company also increased its Authorized Share Capital to Rs. 300 crores and altered its Articles of Association to include a 'Further Issue of Capital' clause. Shareholder approval via postal ballot will be sought. The funds are intended to support the company's growth plans and business strategy for the fiscal year.
This preferential issuance will dilute existing shareholders as new shares or warrants are issued to selected allottees. The significant Rs. 200 crore fundraise could be negative for existing shareholders due to dilution, though the capital injection may support future growth.